Mats Eriksson1, O Finnström. 1. Department of Paediatrics, Orebro University Hospital, SE-701 85 Orebro, Sweden. mats.eriksson@orebroll.se
Abstract
AIM: Orally administered sweet solutions have a pain-relieving effect during painful procedures in newborn infants. The underlying mechanism is not fully understood, but, from the results of animal research, an opioid-like mechanism is often suggested. The aim of this study was to determine whether repeated doses of orally administered glucose would cause tolerance to glucose. METHODS:Fifty-seven healthy, full-term infants were recruited on the day of birth to receive three daily doses of either 1 ml 30% glucose or sterile water for 3-5 d, after which routine blood samples were collected by heel-lance. All infants received 1 ml 30% glucose before the heel-lance was carried out. Crying time, Premature Infant Pain Profile scores and changes in heart rate were used as pain measures. RESULTS: No differences were found between the groups, either in demographic data or in the outcome variables. CONCLUSION: No tolerance was observed under the conditions prevailing in this study. However, we cannot rule out an endogenous opioid mechanism. What is clinically important is that repeated doses of glucose do not decrease the pain-relieving effect.
RCT Entities:
AIM: Orally administered sweet solutions have a pain-relieving effect during painful procedures in newborn infants. The underlying mechanism is not fully understood, but, from the results of animal research, an opioid-like mechanism is often suggested. The aim of this study was to determine whether repeated doses of orally administered glucose would cause tolerance to glucose. METHODS: Fifty-seven healthy, full-term infants were recruited on the day of birth to receive three daily doses of either 1 ml 30% glucose or sterile water for 3-5 d, after which routine blood samples were collected by heel-lance. All infants received 1 ml 30% glucose before the heel-lance was carried out. Crying time, Premature InfantPain Profile scores and changes in heart rate were used as pain measures. RESULTS: No differences were found between the groups, either in demographic data or in the outcome variables. CONCLUSION: No tolerance was observed under the conditions prevailing in this study. However, we cannot rule out an endogenous opioid mechanism. What is clinically important is that repeated doses of glucose do not decrease the pain-relieving effect.
Authors: Dan Ni Wang; Kyla Lavery; Stacey Dalgleish; Alexandra Howlett; Vivian E Hill; Stephanie A Dotchin Journal: J Perinatol Date: 2020-10-15 Impact factor: 2.521
Authors: Débora Joyce Duarte Oliveira; Kleyton Santos Medeiros; Ayane Cristine Alves Sarmento; Francisca Jennifer Duarte Oliveira; Ana Paula Ferreira Costa; Nilba Lima Souza; Ana Katherine Gonçalves; Maria de Lourdes Costa Silva Journal: BMJ Open Date: 2021-12-09 Impact factor: 2.692
Authors: Cian Wade; John Scott Frazer; Evelyn Qian; Lien M Davidson; Suzanne Dash; Anna Te Water Naudé; Rema Ramakrishan; Jalemba Aluvaala; Kokila Lakhoo; Mike English Journal: Lancet Child Adolesc Health Date: 2020-07-28